Pulmonary function tests and thyroid hormone concentrations in patients with chronic obstructive pulmonary disease

Medical Principles and Practice

Volumn 13, Issue 3, 2004, Pages 126-128

  Okutan, Oguzhan ^a,b   Kartaloglu, Zafer ^a   Onde, Mehmet Emin ^a   Bozkanat, Erkan ^a   Kunter, Erdogan ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Free 3,5,3 triiodothyronine; Free thyroxine; Pulmonary function test; Thyroid; Thyroid stimulating hormone

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; AGED; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; PEAK EXPIRATORY FLOW; SCINTIGRAPHY; THYROID FUNCTION; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KUWAIT; MALE; MIDDLE AGED; OXYGEN; PEAK EXPIRATORY FLOW RATE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THYROID HORMONES; THYROTROPIN; THYROXINE; VITAL CAPACITY;

EID: 1842507651     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076950     Document Type: Article

References (12)

1. World Health Organization: World Health Report. Geneva, World Health Organization, 2000.
2. Beers MH, Berkow R: The Merck Manuel, ed 17. Whitehouse Station, Merck, 1999, p 575.
3. Bratel T, Wennlund A, Carlstrom K: Impact of hypoxaemia on neuroendocrine function and catecholamine secretion in chronic obstructive pulmonary disease (COPD): Effects of long-term oxygen treatment. Respir Med 2000;94:1221-1228.
4. Gow SM, Seth J, Beckett GJ, Douglas G: Thyroid function and endocrine abnormalities in elderly patients with severe chronic obstructive lung disease. Thorax 1987;42:520-525.
5. Semple PD, Beastall GH, Watson WS, Hume R: Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981;36:605-609.
6. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Rep. National Heart, Lung, and Blood Institute, Publ No 2701, 2001, p 7.
7. Pechatnikov LM: Significance of hypophyseothyroid disorders in chronic obstructive bronchitis. Klin Med (Mosk) 1989;67:40-43.
8. Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras DA: Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism 2001;50:1397-1401.
9. Banks WA, Cooper JA: Hypoxia and hypercarbia of chronic lung disease: Minimal effects on anterior pituitary function. South Med J 1990;83:290-293.
10. Hikita T, Fukutani K, Yamamoto Y, Yoshimizu N, Sasaki T: Effect of aminophylline injection on the pituitary-thyroid axis in asthmatics. Jpn J Med 1989;28:303-308.
11. Fukutani K: Effects of long-term administration of theophylline on the pituitary-thyroid axis in asthmatics. Arerugi 1991;40:1176-1185.
12. Hiritani M, Muto K, Oshida Y, Ito S, Kasei M, Ueda S, Sato T: Effect of sustained-release theophylline administration on pituitary-thyroid axis. J Allergy Clin Immunol 1982;70:481-485.